XORTX Therapeutics (XRTX) Total Non-Current Liabilities (2020 - 2026)
XORTX Therapeutics' Total Non-Current Liabilities was $678,522 in the quarter ended Jun 30, 2026, up 27.0% from $534,455 a year earlier but down 21.1% from the prior quarter.
Powered by 
Analysis
XORTX Therapeutics (XRTX) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
As of Dec 31, 2025, Total Non-Current Liabilities at XORTX Therapeutics came in at $591,071, up 217.8% from the prior year.
- Total Non-Current Liabilities shows a four-year compound annual growth rate of 1.4% (years ended Dec 2021 to Dec 2025).
- In earlier years, Total Non-Current Liabilities was $185,990 in the year ended Dec 31, 2024 (-36.9%), $294,938 in the year ended Dec 31, 2023 (-92.4%), $3.87 million in the year ended Dec 31, 2022 (+591.1%) and $559,366 in the year ended Dec 31, 2021.
- Quarterly Total Non-Current Liabilities has moved between -$13.17 million (the quarter ended Sep 30, 2021) and $1.52 million (the quarter ended Dec 31, 2022) over five years.
- Compared with a year earlier, Total Non-Current Liabilities has increased for six straight quarters, with growth averaging 60.9% over the last seven quarters.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was the quarter ended Dec 31, 2025 (growth of 217.8%); the worst was the quarter ended Dec 31, 2023 (a decline of 80.6%).
- Per Business Quant data, XRTX's Total Non-Current Liabilities in the three quarters before the quarter ended Jun 30, 2026 was $859,988 (quarter ended Mar 31, 2026), $591,071 (quarter ended Dec 31, 2025) and $736,408 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | XORTX Therapeutics | 893,236.25 | -2.41 Mn | - | 678,522.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 678,522.00 |
| Mar 31, 2026 | 859,988.00 |
| Dec 31, 2025 | 591,071.00 |
| Sep 30, 2025 | 736,408.00 |
| Jun 30, 2025 | 534,455.00 |
| Mar 31, 2025 | 431,350.00 |
| Dec 31, 2024 | 185,990.00 |
| Sep 30, 2024 | 387,751.00 |
| Jun 30, 2024 | 521,644.00 |
| Mar 31, 2024 | 23.71 Mn |
| Dec 31, 2023 | 294,938.00 |
| Sep 30, 2023 | 529,011.00 |
| Jun 30, 2023 | 378,516.00 |
| Mar 31, 2023 | 575,042.00 |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 1.45 Mn |
| Jun 30, 2022 | 819,756.63 |
| Mar 31, 2022 | 685,648.48 |
| Dec 31, 2021 | 550,044.69 |
| Sep 30, 2021 | 11.97 Mn |
API Access
XORTX Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=XRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "XRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=XRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();